234 related articles for article (PubMed ID: 30016577)
1. Heparin-protamine balance after neonatal cardiopulmonary bypass surgery.
Peterson JA; Maroney SA; Zwifelhofer W; Wood JP; Yan K; Bercovitz RS; Woods RK; Mast AE
J Thromb Haemost; 2018 Oct; 16(10):1973-1983. PubMed ID: 30016577
[TBL] [Abstract][Full Text] [Related]
2. Optimal protamine dosing after cardiopulmonary bypass: The PRODOSE adaptive randomised controlled trial.
Miles LF; Burt C; Arrowsmith J; McKie MA; Villar SS; Govender P; Shaylor R; Tan Z; De Silva R; Falter F
PLoS Med; 2021 Jun; 18(6):e1003658. PubMed ID: 34097705
[TBL] [Abstract][Full Text] [Related]
3. An Adjusted Calculation Model Allows for Reduced Protamine Doses without Increasing Blood Loss in Cardiac Surgery.
Kjellberg G; Sartipy U; van der Linden J; Nissborg E; Lindvall G
Thorac Cardiovasc Surg; 2016 Sep; 64(6):487-93. PubMed ID: 26270199
[TBL] [Abstract][Full Text] [Related]
4. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
[TBL] [Abstract][Full Text] [Related]
5. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
[TBL] [Abstract][Full Text] [Related]
6. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients.
Shore-Lesserson L; Reich DL; DePerio M
Can J Anaesth; 1998 Jan; 45(1):10-8. PubMed ID: 9466020
[TBL] [Abstract][Full Text] [Related]
7. The effects of protamine overdose on coagulation parameters as measured by the thrombelastograph.
Khan NU; Wayne CK; Barker J; Strang T
Eur J Anaesthesiol; 2010 Jul; 27(7):624-7. PubMed ID: 20485179
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulation management during multivessel coronary artery bypass grafting: a randomized trial comparing individualized heparin management and conventional hemostasis management.
Hoenicka M; Rupp P; Müller-Eising K; Deininger S; Kunert A; Liebold A; Gorki H
J Thromb Haemost; 2015 Jul; 13(7):1196-206. PubMed ID: 25954849
[TBL] [Abstract][Full Text] [Related]
9. Heparin reversal in off-pump coronary artery bypass surgery: complete, partial, or no reversal?
Gatti G; Pugliese P
Cardiovasc Surg; 2002 Jun; 10(3):245-50. PubMed ID: 12044433
[TBL] [Abstract][Full Text] [Related]
10. Protamine reduces whole blood platelet aggregation after cardiopulmonary bypass.
Olsson A; Alfredsson J; Håkansson E; Svedjeholm R; Berglund J; Berg S
Scand Cardiovasc J; 2016; 50(1):58-63. PubMed ID: 26402229
[TBL] [Abstract][Full Text] [Related]
11. Increased accuracy in heparin and protamine administration decreases bleeding: a pilot study.
Runge M; Møller CH; Steinbrüchel DA
J Extra Corpor Technol; 2009 Mar; 41(1):10-4. PubMed ID: 19361026
[TBL] [Abstract][Full Text] [Related]
12. Predicting and treating coagulopathies after cardiopulmonary bypass in children.
Miller BE; Mochizuki T; Levy JH; Bailey JM; Tosone SR; Tam VK; Kanter KR
Anesth Analg; 1997 Dec; 85(6):1196-202. PubMed ID: 9390579
[TBL] [Abstract][Full Text] [Related]
13. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
[TBL] [Abstract][Full Text] [Related]
14. Validation of viscoelastic coagulation tests during cardiopulmonary bypass.
Ortmann E; Rubino A; Altemimi B; Collier T; Besser MW; Klein AA
J Thromb Haemost; 2015 Jul; 13(7):1207-16. PubMed ID: 25903995
[TBL] [Abstract][Full Text] [Related]
15. Extreme Plasma Dilution Decreases Heparin and Protamine Cardiopulmonary Bypass Requirements: A Case Report on a Jehovah's Witness Patient.
Chang E; Gatling JW; Bode S; Herrmann PC; Bull BS; Applegate RL
A A Case Rep; 2017 Jun; 8(11):291-293. PubMed ID: 28328588
[TBL] [Abstract][Full Text] [Related]
16. Automated protamine dose assay in heparin reversal management after cardiopulmonary by pass.
Guarracino F; De Cosmo D; Penzo D; Tedesco M; Bossi A; Zussa C; Polesel E; De Stefani R
Minerva Anestesiol; 2001 Apr; 67(4):165-9. PubMed ID: 11376504
[TBL] [Abstract][Full Text] [Related]
17. Measurement of thrombin generation intra-operatively and its association with bleeding tendency after cardiac surgery.
Bosch YP; Al Dieri R; ten Cate H; Nelemans PJ; Bloemen S; de Laat B; Hemker C; Weerwind PW; Maessen JG; Mochtar B
Thromb Res; 2014 Mar; 133(3):488-94. PubMed ID: 24388571
[TBL] [Abstract][Full Text] [Related]
18. Protamine overdose and its impact on coagulation, bleeding, and transfusions after cardiopulmonary bypass: results of a randomized double-blind controlled pilot study.
Koster A; Börgermann J; Gummert J; Rudloff M; Zittermann A; Schirmer U
Clin Appl Thromb Hemost; 2014 Apr; 20(3):290-5. PubMed ID: 23564056
[TBL] [Abstract][Full Text] [Related]
19. Is 300 Seconds ACT Safe and Efficient during MiECC Procedures?
Bauer A; Hausmann H; Schaarschmidt J; Szlapka M; Scharpenberg M; Eberle T; Hasenkam JM
Thorac Cardiovasc Surg; 2019 Apr; 67(3):191-202. PubMed ID: 29290078
[TBL] [Abstract][Full Text] [Related]
20. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
Taneja R; Marwaha G; Sinha P; Quantz M; Stitt L; Gao R; Subramanian S; Schaus M; Keeney M; Chin-Yee I; Murkin J
Can J Anaesth; 2009 Jul; 56(7):489-96. PubMed ID: 19408066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
